Fresenius Medical Care AG
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a FMCQF research report →
About the company
Fresenius Medical Care AG engages in the provision of products and services for individuals with renal diseases. It operates through the Care Enablement and Care Delivery segments. The Care Enablement segment is involved in the healthcare products business including research and development, manufacturing, supply chain, and commercial operations as well as supporting functions, such as regulatory and quality management.
- CEO
- Helen Giza
- IPO
- 2012
- Employees
- 110,361
- HQ
- Bad Homburg, BC, DE
Price Chart
- Market Cap
- $11.98B
- P/E
- 12.53
- P/S
- 0.57
- P/B
- 0.85
- EV/EBITDA
- 6.00
- Div Yield
- 3.63%
- Gross Margin
- 25.96%
- Op Margin
- 10.17%
- Net Margin
- 4.88%
- ROE
- 7.16%
- ROIC
- 5.76%
- Revenue
- $19.62B · 1.47%
- Net Income
- $977.63M · 81.75%
- EPS
- $3.35 · 83.06%
- Op Income
- $1.84B
- FCF YoY
- 4.64%
- 52W High
- $57.07
- 52W Low
- $42.00
- 50D MA
- $43.91
- 200D MA
- $47.18
- Beta
- 0.82
- Avg Volume
- 45
Get TickerSpark's AI analysis on FMCQF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our FMCQF coverage
Recent articles, reports, and earnings notes.
No research on FMCQF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate FMCQF report →Similar companies
Peers in the same neighborhood.